Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK opens US hub for vaccine manufacturing

January 14, 2009
Manufacturing and Production GSK

GlaxoSmithKline has officially unveiled a $300 million manufacturing plant in Pennsylvania that will serve as the cornerstone of its US …

News

A postcard from … Spain

January 14, 2009
Research and Development, Sales and Marketing Spain, healthcare, pharma

Feature

Wellcome Trust backs epigenetics project

January 13, 2009
Research and Development epigenetics

A public-private partnership aiming to determine the three-dimensional structure of medically-relevant proteins and put them in the public domain has …

News

Getting up to speed with India

January 12, 2009
Research and Development India, clinical trials, ethics

On a recent trip I made to India, the resourcefulness of the country's people was demonstrated to me as soon …

Feature

End of the line for European paracetamol

January 12, 2009
Manufacturing and Production EU

The last European plant manufacturing paracetamol closed for the final time at the turn of the year, another sign that …

News

Actavis agrees deal with FDA on manufacturing problems

January 9, 2009
Manufacturing and Production Actavis

Generic drug manufacturer Actavis will continue the lockdown of its New Jersey manufacturing facilities that breached quality standards, but hopes …

News

UK biotech forced to hang on for government aid

January 9, 2009
Research and Development biotech

Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …

News

UK pharma to lose

January 8, 2009
Sales and Marketing ABPI, NHS, par

The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …

News

Lifeline for troubled LyondellBasell

January 8, 2009
Manufacturing and Production Lyondell, excipients

LyondellBasell, the world’s third-largest petrochemical company and a supplier of a number of pharmaceutical raw materials, has filed for Chapter …

News

Novartis boosts vaccine pipeline

January 8, 2009
Research and Development, Sales and Marketing Novartis, recruitment, vaccines

Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …

News

Pfizer to develop vaccines with Cytos

January 8, 2009
Research and Development, Sales and Marketing Cytos, Pfizer

News

Working Life: Les Hughes

January 8, 2009
Research and Development AstraZeneca, Cancer, clinical research, infection

How did you find your way into your role? I wanted to be a chemist from my very first experience …

Feature

Government ups the ante on GP surveys

January 7, 2009
NHS, primary

Patients are to be surveyed more often in a government bid to further improve GP services. The survey has been …

News

PMCPA cautions on the way new prices are promoted

January 7, 2009
Sales and Marketing par, reg

UK pharma companies have been warned not to mislead doctors about new lower prices of medicines. Code of Practice regulator …

News

The Pharmafocus Interview: Elmar Schnee

January 6, 2009
Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness

Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

Feature

NICE makes end-of-life drugs more available

January 6, 2009
Sales and Marketing NICE, par

High-cost drugs that extend the lives of terminally ill patients will be more readily approved for NHS use, thanks to …

News

Most acute NHS trusts independent from government

January 5, 2009
NHS

More than half of all acute NHS trusts have now been awarded foundation status, making them free to operate outside …

News

GSK halts political funding

January 5, 2009
Sales and Marketing GSK, ethics

GlaxoSmithKline will no longer make corporate political donations in a bid to make its dealings with governments more transparent and …

News

Reforms launched with call for action on European competitiveness

January 2, 2009
Sales and Marketing EU, hc, reform

News

Abraxis Biosciences launches Abraxane in Europe

January 2, 2009
Sales and Marketing Abraxis, Cancer, EU

US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025